I. - Basic information

I.1 - Surname

Petrová

I.2 - Name

Miriam

I.3 - Degrees

MD, PhD

I.4 - Year of birth

19.01.1981

I.5 - Name of the workplace

Institute of Pharmacology and Clinical Pharmacology, FM CU

I.6 - Address of the workplace

Sasinkova 4, 811 08 Bratislava

I.7 - Position

assistant

I.8 - E-mail address

petrova1@uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/5244

I.10 - Name of the study field in which a person works at the university

Pharmacology, Clinical Pharmacology

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Medicine, Comenius University in Bratislava

II.b - Year

2007

II.c - Study field and programme

General Medicine

II.3 - Third degree of higher education

II.a - Name of the university or institution

Institute of Pharmacology and Clinical Pharmacology, FM CU Bratislava

II.b - Year

2012

II.c - Study field and programme

Clinical Pharmacology

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
assistant, PhD student	Institute of Pharmacology and Clinical Pharmacology, FM CU Bratislava	2007 - 2012
assistant	Institute of Pharmacology and Clinical Pharmacology, FM CU Bratislava	2012 until now

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
Using Team-Based Learning in Medical Education	Comenius University in cooperation with lecturers from NYU	2018
Team Based Learning course	Department of Medical Education and Simulations, FM CU	2024
Course/workshop for creating E-learning courses in the Moodle system	Department of Medical Education and Simulations, FM CU	2024

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pharmacology	General medicine	I. + II.	General Medicine
Pharmacology	Dentistry	I. + II.	Dentistry
Clinical Pharmacology	General Medicine	I. + II.	General Medicine

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.2 - Number of defended theses

V.4.b - Diploma (second degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

VI.1.b - Over the last six years

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

V3 Wawruch M, Petrova M, Tesar T, Murin J, Schnorrerova P, Paduchova M, Celovska D, Havelkova B, Trnka M, Alfian SD, Aarnio E. Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease. Front Pharmacol. 2023; 14: 1199669. (2022: 5.6 – IF, Q1 – JCR, Q1 – SJR)

ADC Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Matalova P, Havelkova B, Trnka M, Aarnio E. Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease. Biomedicines. 2021; 9 (12): 1800. (2020: 6.081 – IF, Q1 – JCR, Q1 – SJR)

ADC Dobiaš L, Petrová M, Vojtko R, Uličná O, Vančová O, Kristová V. Effect of sulodexide on vascular responses and liver mitochondrial function in diabetic rats. Physiol Res. 2015; 64 (Suppl 4): S497-505. (2014: 1.293 – IF, Q4 – JCR, Q2 – SJR)

VI.3 - The most significant research/artistic/other outputs over the last six years

V3 Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease. Biomedicines. 2022; 10 (7):1479. (2021: 4.757 – IF, Q2 – JCR, Q1 –SJR)

V3 Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Aarnio E. Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease. Biomedicines. 2021; 9 (9): 1280. (2020: 6.081 – IF, Q1 – JCR, Q1 – SJR)

ADC Wawruch M, Murin J, Tesar T, Paduchova M, Petrova M, Celovska D, Havelkova B, Trnka M, Aarnio E. Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease. Front Pharmacol. 2021; 12: 687549. (2020: 5.811 – IF, Q1 – JCR, Q1 – SJR)

ADC Wawruch M, Wimmer G, Murín J, Paduchová M, Petrová M, Tesař T, Matalová P, Havelková B, Trnka M, Aarnio E. Non-adherence to statin treatment in older patients with peripheral arterial disease depending on persistence status. Biomedicines. 2020; 8 (10): 378. (2019: 4.717 – IF, Q1 – JCR, Q1 – SJR)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

V3 Wawruch M, Murin J, Tesar T, Petrova M, Paduchova M, Celovska D, Havelkova B, Trnka M, Masarykova L, Alfian SD, Aarnio E. Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines. 2023; 11 (2): 368. cit.: [n1] 2024 Piechocki, M. - Przewlocki, T. - Pieniazek, P. - Trystula, M. - Podolec, J. - Kablak-Ziembicka, A. : A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review PART II-Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory. In: Journal of Clinical Medicine, vol. 13, no. 5, 2024. art. no. 1508 - SCI ; SCOPUS

ADC Behuliak M, Pintérová M, Bencze M, Petrová M, Líšková S, Karen P, Kuneš J, Vaněčková I, Zicha J. Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 2013; 31 (10):2025-35. cit: [o1] 2014 ~ Mizuno, M. - Iwamoto, G.A. - Vongpatanain, W. - Mitchell, J.H. - Smith, S.A.: American Journal of Physiology - Heart and Circulatory Physiology, vol. 307, no. 2, 2014, s. H242-H251 -- SCI ; SCOPUS

ADC Líšková S, Petrová M, Karen P, Kuneš J, Zicha J. Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. Eur J Pharmacol. 2011; 667 (1-3):265-70. cit. [o1] 2019 ~ Paz, A.A. - Arenas, G.A. - Castillo-Galán, S. - Penaloza, E. - Cáceres-Rojas, G. - Suazo, J. - Herrera, E.A. - Krause, B.J.: International Journal of Molecular Sciences, vol. 20, no. 14, 2019, art. no. 3474 -- SCI ; SCOPUS

ADC Lísková S, Petrová M, Karen P, Kunes J, Zicha J. Influence of calcium-dependent potassium channel blockade and nitric oxide inhibition on norepinephrine-induced contractions in two forms of genetic hypertension. J Am Soc Hypertens. 2010; 4 (3):128-34. cit. [o1] 2021 ~ Matsumoto, T. - Takayanagi, K. - Katome, T. - Kojima, M. - Taguchi, K. - Kobayashi, T.: Pharmacology, vol. 106, no. 7-8, 2021, s. 435-445 -- SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

2021-2024 Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic - VEGA 1/0024/21 (scientific co-worker) "Possibilities of pharmacoepidemiologic analysis of adherence to preventive pharmacotherapy in older patients with peripheral arterial disease of lower limbs"

2017-2019 Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic - VEGA 1/0112/17 (scientific co-worker) "Adherence with pharmacotherapy – a basic precondition of successful secondary prevention of cardiovascular diseases in elderly patients"

2021 - 2023 European Regional Development Fund – No. 313011AVG3 – (scientific co-worker) "Development of biomodels to improve the evaluation of the efficacy of drugs and substances that have potential in the treatment of COVID-19 (BIOVID-19)"

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution	VIII.b - Address of the institution	VIII.c - Duration (indicate the duration of stay)	VIII.d - Mobility scheme, employment contract, other (describe)
Czech Academy of Sciences, Institute of Physiology	Vídeňská 1083, 142 00 Praha 4	summer 2009, summer 2010, summer 2011	professional internship

Name and surname:	MUDr. Miriam Petrová, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava